切换至 "中华医学电子期刊资源库"

中华肺部疾病杂志(电子版) ›› 2021, Vol. 14 ›› Issue (02) : 253 -255. doi: 10.3877/cma.j.issn.1674-6902.2021.02.031

综述

高毒力肺炎克雷伯菌的研究进展
张慧芳1, 王瑞兰1,()   
  1. 1. 201620 上海,上海交通大学附属第一人民医院急诊危重病科
  • 收稿日期:2020-11-21 出版日期:2021-04-25
  • 通信作者: 王瑞兰
  • 基金资助:
    上海科学技术委员会科技支撑项目(18411950620)

Research Progress of Klebsiella pneumonia

Huifang Zhang1, Ruilan Wang1()   

  • Received:2020-11-21 Published:2021-04-25
  • Corresponding author: Ruilan Wang
引用本文:

张慧芳, 王瑞兰. 高毒力肺炎克雷伯菌的研究进展[J]. 中华肺部疾病杂志(电子版), 2021, 14(02): 253-255.

Huifang Zhang, Ruilan Wang. Research Progress of Klebsiella pneumonia[J]. Chinese Journal of Lung Diseases(Electronic Edition), 2021, 14(02): 253-255.

1
Akova M, Daikos GL, Tzouvelekis L, et al. Interventional strategies and current clinical experience with carbapenemase-producing Gram-negative bacteria[J]. Clin Microbiol Infect, 2012, 18(5): 439-448.
2
胡付品,郭 燕,朱德妹,等. 2016年中国CHINET细菌耐药性监测[J]. 中国感染与化疗杂志,2017, 17(5): 481-491.
3
Liu YC, Cheng DL, Lin CL. Klebsiella pneumoniae liver abscess associated with septic endophthalmitis[J]. Arch Intern Med, 1986, 146(10): 1913-1916.
4
Wu H, Li DD, Zhou HJ, et al. Bacteremia and other body site infection caused by hypervirulent and classic Klebsiella pneumoniae[J]. Microb Pathog, 2017, 104: 254-262.
5
Russo TA, Marr CM. Hypervirulent Klebsiella pneumoniae[J]. Clin Microbiol Rev, 2019, 32(3): e00001-19.
6
Jervey LP Jr. The treatment of acute friedlaender′s bacillus pneumonia;a continuing problem[J]. AMA Arch Intern Med, 1957, 99(1): 1-7.
7
Ritvo M, Martin F. The clinical and roentgen manifestations of pneumonia due to Bacillus mucosus capsulatus (primary Friedlander pneumonia)[J]. Am J Roentgenol Radium Ther, 1949, 62(2): 211-222.
8
Fung CP, Chang FY, Lee SC, et al. A global emerging disease of Klebsiella pneumoniae liver abscess: is serotype K1 an important factor for complicated endophthalmitis?[J]. Gut, 2002, 50(3): 420-424.
9
Bensley EH. A Case of Friedlander's Pneumonia[J]. Can Med Assoc J , 1932, 26(6): 681-684.
10
Lam MMC, Wyres KL, Duchene S, et al. Population genomics of hypervirulent Klebsiella pneumoniae clonal-group 23 reveals early emergence and rapid global dissemination[J]. Nat Commun, 2018, 9(1): 2703.
11
Nassif X, Sansonetti PJ. Correlation of the virulence of Klebsiella pneumoniae K1 and K2 with the presence of a plasmid encoding aerobactin[J]. Infect Immun, 1986, 54(3): 603-608.
12
Nassif X, Honore N, Vasselon T, et al. Positive control of colanic acid synthesis in Escherichia coli by rmpA and rmpB, two virulence-plasmid genes of Klebsiella pneumoniae[J]. Mol Microbiol, 1989, 3(10): 1349-1359.
13
Chen YT, Chang HY, Lai YC, et al. Sequencing and analysis of the large virulence plasmid pLVPK of Klebsiella pneumoniae CG43[J]. Gene, 2004, 337: 189-198.
14
Wu KM, Li LH, Yan JJ, et al. Genome sequencing and comparative analysis of Klebsiella pneumoniae NTUH-K2044, a strain causing liver abscess and meningitis[J]. J Bacteriol, 2009, 191(14): 4492-4501.
15
Gu D, Dong N, Zheng Z, et al. A fatal outbreak of ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae in a Chinese hospital: a molecular epidemiological study[J]. Lancet Infect Dis, 2018, 18(1): 37-46.
16
Yu WL, Ko WC, Cheng KC, et al. Comparison of prevalence of virulence factors for Klebsiella pneumoniae liver abscesses between isolates with capsular K1/K2 and non-K1/K2 serotypes[J]. Diagn Microbiol Infect Dis, 2008, 62(1): 1-6.
17
Guo C, Yang X, Wu Y, et al. MLST-based inference of genetic diversity and population structure of clinical Klebsiella pneumoniae, China[J]. Sci Rep, 2015, 5: 7612.
18
Russo TA, Olson R, Fang CT, et al. Identification of biomarkers for differentiation of hypervirulent Klebsiella pneumoniae from classical K. pneumoniae[J]. J Clin Microbiol, 2018, 56(9).
19
Kloos WE, Musselwhite MS. Distribution and persistence of staphylococcus and micrococcus species and other aerobic bacteria on human skin[J]. Appl Microbiol, 1975, 30(3): 381-385.
20
Haryani Y, Noorzaleha AS, Fatimah A B, et al. Incidence of Klebsiella pneumonia in street foods sold in Malaysia and their characterization by antibiotic resistance, plasmid profiling, and RAPD-PCR analysis[J]. Food Control, 2007, 18(7): 847-853.
21
Chung DR, Lee H, Park MH, et al. Fecal carriage of serotype K1 Klebsiella pneumoniae ST23 strains closely related to liver abscess isolates in Koreans living in Korea[J]. Eur J Clin Microbiol Infect Dis, 2012, 31(4): 481-486.
22
Lin YT, Wang YP, Wang FD, et al. Community-onset Klebsiella pneumoniae pneumonia in Taiwan: clinical features of the disease and associated microbiological characteristics of isolates from pneumonia and nasopharynx[J]. Front Microbiol, 2015, 9: 122.
23
Zhang Y, Zhao C, Wang Q, et al. High Prevalence of Hypervirulent Klebsiella pneumoniae Infection in China: Geographic distribution, clinical characteristics, and antimicrobial resistance[J]. Antimicrob Agents Chemother, 2016, 60(10): 6115-6120.
24
Yan Q, Zhou M, Zou M, et al. Hypervirulent Klebsiella pneumoniae induced ventilator-associated pneumonia in mechanically ventilated patients in China[J]. Eur J Clin Microbiol Infect Dis, 2016, 35(3): 387-396.
25
Liu YM, Li BB, Zhang YY, et al. Clinical and molecular characteristics of emerging hypervirulent Klebsiella pneumoniae bloodstream infections in mainland China[J]. Antimicrob Agents Chemother, 2014, 58(9): 5379-5385.
26
Li W, Sun G, Yu Y, et al. Increasing occurrence of antimicrobial-resistant hypervirulent (hypermucoviscous) Klebsiella pneumoniae isolates in China[J]. Clin Infect Dis, 2014, 58(2): 225-232.
27
Khaertynov KS, Anokhin VA, Davidyuk YN, et al. Case of meningitis in a neonate caused by an extended-spectrum-beta-lactamase-producing strain of hypervirulent klebsiella pneumoniae[J]. Front Microbiol, 2017, 8: 1576.
28
Surgers L, Boyd A, Girard PM, et al. ESBL-producing strain of hypervirulent Klebsiella pneumoniae K2, France[J]. Emerg Infect Dis, 2016, 22(9): 1687-1688.
29
Shankar C, Santhanam S, Kumar M, et al. Draft genome sequence of an extended-spectrum-beta-lactamase-positive hypervirulent Klebsiella pneumoniae strain with novel sequence type 2318 isolated from a neonate[J]. Genome Announc, 2016, 4(6): e01273-16.
30
Yao B, Xiao X, Wang F, et al. Clinical and molecular characteristics of multi-clone carbapenem-resistant hypervirulent (hypermucoviscous) Klebsiella pneumoniae isolates in a tertiary hospital in Beijing, China[J]. Int J Infect Dis, 2015, 37: 107-112.
31
Mohammad Ali Tabrizi A, Badmasti F, Shahcheraghi F, et al. Outbreak of hypervirulent Klebsiella pneumoniae harbouring blaVIM-2 among mechanically-ventilated drug-poisoning patients with high mortality rate in Iran[J]. J Glob Antimicrob Resist, 2018, 15: 93-98.
32
Roulston KJ, Bharucha T, Turton JF, et al. A case of NDM-carbapenemase-producing hypervirulent Klebsiella pneumoniae sequence type 23 from the UK[J]. JMM Case Rep, 2018, 5(9): e005130.
33
Liu YY, Wang Y, Walsh TR, et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study[J]. Lancet Infect Dis, 2016, 16(2): 161-168.
34
Gu DX, Huang YL, Ma JH, et al. Detection of colistin resistance gene mcr-1 in hypervirulent Klebsiella pneumoniae and escherichia coli isolates from an infant with diarrhea in China[J]. Antimicrob Agents Chemother, 2016, 60(8): 5099-5100.
35
Choi MJ, Ko KS. Loss of hypermucoviscosity and increased fitness cost in colistin-resistant Klebsiella pneumoniae sequence type 23 strains[J]. Antimicrob Agents Chemother, 2015, 59(11): 6763-6773.
36
Huang YH, Chou SH, Liang SW, et al. Emergence of an XDR and carbapenemase-producing hypervirulent Klebsiella pneumoniae strain in Taiwan[J]. J Antimicrob Chemother, 2018, 73(8): 2039-2046.
37
Goncalves GB, Furlan JPR, Vespero EC, et al. Spread of multidrug-resistant high-risk Klebsiella pneumoniae clones in a tertiary hospital from southern Brazil[J]. Infect Genet Evol, 2017, 56: 1-7.
38
Martin RM, Cao J, Brisse S, et al. Molecular Epidemiology of colonizing and infecting isolates of Klebsiella pneumoniae[J]. mSphere, 2016, 1(5): e00261-16.
[1] 白若靖, 郭军. 肺炎克雷伯菌肺炎与干扰素信号通路关系研究进展[J]. 中华实验和临床感染病杂志(电子版), 2024, 18(02): 71-74.
[2] 朱琳, 陈韬, 张慎, 许东. 华中地区某三甲医院感染科近十年病原菌结构及耐药性变迁[J]. 中华实验和临床感染病杂志(电子版), 2024, 18(02): 75-82.
[3] 尹燕燕, 刘爱贤. 多重耐药菌感染呼吸机相关性肺炎的危险因素及预后分析[J]. 中华实验和临床感染病杂志(电子版), 2024, 18(02): 83-90.
[4] 袁柳凤, 徐文绮, 朱小宇, 王慧珠, 伦文辉. 283株淋球菌对七种常见抗菌药物的耐药性分析[J]. 中华实验和临床感染病杂志(电子版), 2024, 18(02): 108-112.
[5] 巨春蓉, 门同义, 薛武军. 实体器官移植后难治性/耐药性巨细胞病毒感染诊疗进展[J]. 中华移植杂志(电子版), 2024, 18(02): 86-92.
[6] 燕红玲, 王岩岩, 陈树斌. PCT、NLR联合LUBS预测ICU CRKP致呼吸机相关肺炎撤机及预后分析[J]. 中华肺部疾病杂志(电子版), 2024, 17(04): 617-620.
[7] 殷国青, 曾莉, 贺斌峰, 孙芬芬. Rab26负性调控Nrf2增强肺癌耐药细胞对奥希替尼的敏感性[J]. 中华肺部疾病杂志(电子版), 2024, 17(03): 349-355.
[8] 王蕊, 林先萍, 李盼盼. 铜绿假单胞菌感染肺炎菌血症危险因素及耐药性分析[J]. 中华肺部疾病杂志(电子版), 2024, 17(03): 478-480.
[9] 庞红燕, 宫艳格, 王瑶杰, 孙海鹏, 张连勇. TTF-1与非小细胞肺癌铂类药物化疗相关性分析[J]. 中华肺部疾病杂志(电子版), 2024, 17(02): 303-306.
[10] 张剑, 卢从华, 李江华, 林采余, 吴迪, 王治国, 聂乃夫, 何勇, 李力. 根据转录组学分析奥希替尼获得性耐药机制的研究[J]. 中华肺部疾病杂志(电子版), 2024, 17(02): 195-200.
[11] 王向前, 李清峰, 陈磊, 丘文丹, 姚志成, 李熠, 吴荣焕. 姜黄素抑制肝细胞癌索拉非尼耐药作用及其调控机制[J]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 729-735.
[12] 杨磊, 汪美华, 胡锦. 急性脑梗死去骨瓣术后合并碳青霉烯耐药肺炎克雷伯菌感染一例[J]. 中华重症医学电子杂志, 2024, 10(02): 200-204.
[13] 徐靖亭, 孔璐. PARP抑制剂治疗卵巢癌的耐药机制及应对策略[J]. 中华临床医师杂志(电子版), 2024, 18(06): 584-588.
[14] 虞岱瑶, 冯文莉. 不同状态下SAP2和STP1在白念珠菌伊曲康唑耐药中的作用[J]. 中华临床医师杂志(电子版), 2024, 18(03): 283-294.
[15] 陈怡丽, 刘平娟, 郭鹏豪, 邓间开, 彭雅琴, 伍众文, 刘敏, 陈培松, 廖康. 全国细菌耐药监测网实践培训基地教学质量评价体系的建立与实践[J]. 中华临床实验室管理电子杂志, 2024, 12(03): 155-161.
阅读次数
全文


摘要